Carcinoma in situ of lip, oral cavity and pharynx

DOID MESH PheWeb

CD2_INSITU_LIPORALPHARYNX

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D00.0

Hospital discharge: ICD-9 2300

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D00.0

Cause of death: ICD-9 2300

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

CD2_INSITU_LIPORALPHARYNX

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D00

Name in latin Carcinoma in situ labii (oris)

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ of lip, oral cavity and pharynx based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	40	14	26
Unadjusted prevalence (%)	0.01	0.01	0.02
Mean age at first event (years)	62.50	58.02	64.91

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_LIPORALPHARYNX – Carcinoma in situ of lip, oral cavity and pharynx
GWS hits:

Survival analyses between endpoints

↥

Plot

before Carcinoma in situ of lip, oral cavity and pharynx
after Carcinoma in situ of lip, oral cavity and pharynx

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Carcinoma in situ of lip, oral cavity and pharynx

↥